Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC
Crossref DOI link: https://doi.org/10.1186/s12874-023-01850-7
Published Online: 2023-01-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ismail, R. K.
Schramel, F. M. N. H.
van Dartel, M.
Pasmooij, A. M. G.
der Welle, C. M. Cramer-van
Hilarius, D. L.
de Boer, A.
Wouters, M. W. J. M.
van de Garde, E. M. W.
Text and Data Mining valid from 2023-01-27
Version of Record valid from 2023-01-27
Article History
First Online: 27 January 2023